<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for THLD</title>
    <link />
    <description>Headlines for THRESHOLD PHARMACEUTICALS, INC.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>3 Market Caps With Exceptionally High ROIC</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1452681-3-market-caps-with-exceptionally-high-roic.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 22 May 2013 06:44:52 GMT</pubDate>
    </item>
    <item>
      <title>Agenus 8 Near term Data Drivers with a Market Opportunity over $17 Billion dollars</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/agen/articles/183432/agenus-8-near-term-data-drivers-with-a-market-opportunity-over-17-billion-dollars/2013-04-29.aspx?source=itxwebtxt0000015</link>
      <author>Trefis</author>
      <pubDate>Mon, 29 Apr 2013 09:46:48 GMT</pubDate>
    </item>
    <item>
      <title>Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1377581-agenus-near-term-drivers-with-a-market-opportunity-over-17-billion.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 29 Apr 2013 08:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Threshold: My Biotech Pick Of The Year</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1361021-threshold-my-biotech-pick-of-the-year.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 23 Apr 2013 08:43:25 GMT</pubDate>
    </item>
    <item>
      <title>3 Biotechs And The Feuerstein-Ratain Rule</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1329651-3-biotechs-and-the-feuerstein-ratain-rule.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 09 Apr 2013 09:33:48 GMT</pubDate>
    </item>
    <item>
      <title>Following The Crashing Biotechs - 4 Stocks Ready For Spring</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1326101-following-the-crashing-biotechs-4-stocks-ready-for-spring.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 08 Apr 2013 04:45:59 GMT</pubDate>
    </item>
    <item>
      <title>Is Anything Left for Ziopharm Investors?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/26/is-anything-left-for-ziopharm-investors/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 26 Mar 2013 19:37:00 GMT</pubDate>
    </item>
    <item>
      <title>A Silver Lining in a Sea of Red</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/26/a-silver-lining-in-a-sea-of-red/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 26 Mar 2013 15:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Ziopharm Fails Phase III Trial, Threshold Now The Leader</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1300991-ziopharm-fails-phase-iii-trial-threshold-now-the-leader.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 26 Mar 2013 11:29:40 GMT</pubDate>
    </item>
    <item>
      <title>Threshold Pharmaceuticals - A Derivative Trade On Ziopharm's Upcoming Data</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1294901-threshold-pharmaceuticals-a-derivative-trade-on-ziopharm-s-upcoming-data.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 22 Mar 2013 09:52:18 GMT</pubDate>
    </item>
    <item>
      <title>Why Merrimack Is Poised to Outperform</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/20/why-merrimack-is-poised-to-outperform/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 20 Mar 2013 15:02:00 GMT</pubDate>
    </item>
    <item>
      <title>Threshold Cuts Loss, Misses Sales - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94638/threshold-cuts-loss-misses-sales.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 13 Mar 2013 09:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Threshold Pharmaceuticals: A Biotech Trading At Half Its Intrinsic Value</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1238051-threshold-pharmaceuticals-a-biotech-trading-at-half-its-intrinsic-value.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 04 Mar 2013 05:21:56 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Poised for Breakouts</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-stocks-poised-breakouts.html-25.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 01 Mar 2013 14:37:00 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Investors: Please Don't Make This Mistake</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/22/biotech-investors-please-dont-make-this-mistake/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 22 Feb 2013 15:50:00 GMT</pubDate>
    </item>
    <item>
      <title>A Biotech Winner For 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1213901-a-biotech-winner-for-2013.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 21 Feb 2013 20:25:40 GMT</pubDate>
    </item>
    <item>
      <title>Whoa! These 3 Stocks Outmaneuvered the Dow</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/21/whoa-these-3-stocks-outmaneuvered-the-dow/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 21 Feb 2013 14:48:00 GMT</pubDate>
    </item>
    <item>
      <title>4 Biotech Stocks Under $10 Moving Higher</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/4-biotech-stocks-under-10-moving-higher.html-4.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 21 Feb 2013 08:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Small Cap Movers for Wednesday February 20, 2013</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/long-ideas/13/02/3351789/benzingas-small-cap-movers-for-wednesday-february-20-2013.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 20 Feb 2013 21:37:54 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Piper Jaffray Upgrades Threshold Pharmaceuticals to Overweight on Product Differentiation</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/02/3348075/update-piper-jaffray-upgrades-threshold-pharmaceuticals-.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 20 Feb 2013 07:26:31 GMT</pubDate>
    </item>
  </channel>
</rss>
